Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the EU / 2025-524859-31-00
Authorised, not yet recruiting Phase IV

Patient-Controlled Anesthesia for endoscopic Procedural Sedation – PCAPS study

2025-524859-31-00 · tracked via the Priya Life Science EU tracker
Sponsor
Karolinska Institutet
Sponsor type
Educational Institution
Therapeutic area
Digestive System Diseases
Decision date
11/08/2026
Enrollment target
175
Sites
Sweden

Condition studied

Adenoma

Investigational medicinal product(s)

PROPOFOLALFENTANILMIDAZOLAM

Every trial of Midazolam and Propofol across our registers →

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male

Primary endpoint

Patient satisfaction measured using a validated questionnaire

Endpoint detail

Total dose of propofol delivered (mg), Procedure time, Recovery time, Adverse events, Procedure completion rate

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524859-31-00 on CTIS ↗ ← All trials in the EU